President Trump's Opioid Commission Endorses Senator Portman's Bipartisan STOP Act & Prescription Drug Monitoring Legislation

November 1, 2017 | Press Releases

WASHINGTON, D.C. – U.S. Senator Rob Portman (R-OH) commended President Trump’s opioid commission for releasing a detailed set of recommendations to address the national opioid epidemic.  The report specifically endorses two bipartisan Portman-authored bills, including the Synthetics Trafficking & Overdose Prevention (STOP) Act, which would help stop dangerous synthetic drugs from being shipped into our country via the postal system, and the Prescription Drug Monitoring Act, which would help stop overprescribing.  Portman released the following statement:

“I commend the commission for putting forward a serious and detailed set of recommendations to help address this heroin and prescription drug epidemic.  I am especially pleased that the president’s commission has endorsed the STOP Act and the Prescription Drug Monitoring Act, bipartisan legislation I have championed that will make a real difference in helping to combat this crisis.  It’s time for the Senate to pass both of these bills.  

While Congress has made some progress in addressing this crisis by enacting the Comprehensive Addiction & Recovery Act and the 21st Century CURES Act last year, we can and must do more.  I look forward to fully reviewing all of the commission’s recommendations.  And I am hopeful that Congress will act with urgency in the coming weeks and months to review and address the recommendations outlined in this report.”

NOTE: The opioid commission’s full report can be viewed here.  Senator Portman has been a leader in the Senate’s efforts to combat the opioid crisis. In addition to the bipartisan Synthetics Trafficking & Overdose Prevention (STOP) Act and the Prescription Drug Monitoring Act, Portman is working on several other bipartisan measures to combat this crisis, including the Medicaid CARE Act and CRIB Act.